STAT

FEBRUARY 29, 2024

The outage caused by the Change Healthcare cyberattack could last weeks, a top UnitedHealth executive suggested in a Tuesday conference call with hospital cybersecurity officers, according to a recording obtained by STAT. UnitedHealth Group Chief Operating Officer Dirk McMahon said the company is setting up a loan program to help providers who can’t submit insurance claims while Change is offline.

Hospitals 363

Hospitals 363

PharmaVoice

FEBRUARY 21, 2024

The first-of-its-kind TIL therapy for solid tumors developed by Iovance Biotherapeutics won FDA approval last week.

223

223

The Pharmacist

FEBRUARY 7, 2024

Using Additional Roles Reimbursement Scheme (ARRS) funding for GPs would be ‘ridiculous’ given the difficulty of recruiting doctors and the efficiency of utilising other roles within the surgery, a pharmacist partner in a south coast general practice has said. Shilpa Patel, lead prescribing pharmacist and partner at WellBN health centre in Brighton and Hove, spoke […] The post Adding GPs to ARRS not the way forward, says pharmacist partner appeared first on The Pharmacist.

142

142

pharmaphorum

FEBRUARY 23, 2024

Explore the opportunities and challenges facing rare disease therapies developers, including the impact of Rare Disease Day, FDA regulations, and cutting-edge technologies like CRISPR gene therapy.

138

138

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmaceutical Technology

FEBRUARY 29, 2024

India’s Tata Institute has developed a tablet combining resveratrol and copper that has the potential to prevent the recurrence of cancer.

143

143

BioPharma Dive

FEBRUARY 15, 2024

Analysts pressed Alnylam executives on the reasons for the changes to HELIOS-B, a Phase 3 study in ATTR amyloidosis with cardiomyopathy that is important to the company’s future.

124

124

Express Pharma

FEBRUARY 6, 2024

Rx Propellant (RxP), a platform focused on providing real estate solutions, including research and development (R&D) laboratories and associated facilities for the life sciences and associated sectors in India, has announced an initial investment of $75 million in phase 1 of the Navi Mumbai Research (NMR) District, as part of its continued regional expansion strategy across India.

122

122

The Pharmacist

FEBRUARY 16, 2024

Hundreds of community pharmacies have begun offering a tirzepatide injection as part of a new weight loss service beginning this week. The move follows the approval of a new four-dose version of Mounjaro last month. It is hoped that the new service will expand the availability of private weight-loss treatments amid ongoing shortages of alternatives […] The post Mounjaro weight loss service hoped to ease supply issues appeared first on The Pharmacist.

Community Pharmacies 129

Community Pharmacies Diabetes 129

pharmaphorum

FEBRUARY 14, 2024

Discover how artificial intelligence (AI) is revolutionising the drug development process and transforming the way FDA-approved drugs are produced, ensuring compliance and optimising the supply chain. Learn more about the future of AI in pharmaceuticals.

Drug Development 127

Drug Development 127

Pharmaceutical Technology

FEBRUARY 12, 2024

The UK MHRA has granted approval for a variation in licence of Pfizer-BioNTech’s Comirnaty XBB.1.5 vaccine targeting Omicron variant.

Vaccines 142

Vaccines 142

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

BioPharma Dive

FEBRUARY 7, 2024

The new firm intends to carefully select its startups and fund them for the long haul. “We're not a company formation factory,” said Aaron Kantoff, the firm’s co-founder.

124

124

STAT

FEBRUARY 28, 2024

Of all the lingering symptoms of long Covid , difficulty focusing and thinking, known as brain fog , may be the most frightening and baffling. A new study published Wednesday in the New England Journal of Medicine, which looks at how much cognition is impaired in the months after a coronavirus infection, shows that Covid-19’s impact can be measured in the equivalent of IQ points.

Hospitals 363

Hospitals 363

Pharma Times

FEBRUARY 14, 2024

The aggressive type of cancer accounts for 13% of all lung cancer cases worldwide

Communication 166

Communication 166

The Pharmacist

FEBRUARY 26, 2024

Nearly 400,000 vape kits are set to be sent to smokers in England under the government’s swap-to-stop scheme, our sister title Healthcare Leader has exclusively revealed. At least four integrated care boards (ICBs) and more than 80 localities have expressed interest in the scheme with 379,562 ‘vape starter kits’ requested as of February 2024, data […] The post Nearly 400,000 vape kits to be sent to smokers appeared first on The Pharmacist.

125

125

pharmaphorum

FEBRUARY 19, 2024

Fast approaching the end of its patent life, Roche and Novartis’ Xolair is going out with a bang, picking up a new approval as the first and only drug therapy for people with food allergies in the US.

125

125

Pharmaceutical Technology

FEBRUARY 6, 2024

The potentially disastrous consequences of antimicrobial resistance (AMR) were highlighted at the recent World Economic Forum Meeting 2024.

135

135

BioPharma Dive

FEBRUARY 27, 2024

The biotech’s drug led to significant weight loss in a Phase 2 trial, causing shares to double as analysts compared results to the marks set by drugs from Eli Lilly and Novo Nordisk.

120

120

STAT

FEBRUARY 28, 2024

In 2023, enrollment in Medicare Advantage, the version of Medicare run by private insurers, surpassed 50% of eligible beneficiaries for the very first time. Going by this headline, or perhaps the predictable flood of advertisements for plans during the fall’s open enrollment period, you might be fooled into thinking 2023 was MA’s best year yet.

363

363

Putting Patients First Blog

FEBRUARY 15, 2024

Guest Post: February is Marfan Awareness Month! February 15, 2024 By: April Dawn Shinske, Chief Communications and Marketing Officer, The Marfan Foundation During Marfan Awareness Month 2024, members of the community living with Marfan syndrome — a genetic aortic and vascular condition that impacts connective tissue — have been sharing their diverse perspectives through short videos called #marfanrealreels.

Communication 116

Communication Hospitals 116

The Pharmacist

FEBRUARY 20, 2024

The UK Health Security Agency (UKHSA) is investigating what is behind an 11% rise in tuberculosis cases in England last year. There were 4,850 tuberculosis cases in 2023 compared to 4,380 in 2022, representing a jump of 10.7%, according to provisional data. Even before the Covid-19 pandemic, TB incidence was lower than this, with 4,615 […] The post UKHSA investigating rise in tuberculosis cases appeared first on The Pharmacist.

114

114

pharmaphorum

FEBRUARY 21, 2024

Clinical research involves trial and error as part of the drug development process. Learn more about how to optimise drug trials and the important role of participants in clinical research.

Drug Development 124

Drug Development 124

FDA Law Blog: Biosimilars

FEBRUARY 7, 2024

By John A. Gilbert — Last week, DEA and DOJ announced a $59 million civil penalty settlement with eBay related to the failure to comply with Controlled Substances Act (CSA) requirements for identifying purchasers, maintaining records, and filing reports of individuals selling/purchasing pill presses and encapsulating machines. As stated in the press release , this was the fourth largest civil penalty settlement under the CSA and, ironically, did not involve the sale or distribution of any contr

Controlled Substances 116

Controlled Substances Documentation 116

BioPharma Dive

FEBRUARY 21, 2024

The full results spotlight cell therapy’s potential to treat lupus and other inflammatory conditions, but also the problems drug developers must solve first.

Drug Development 122

Drug Development 122

STAT

FEBRUARY 22, 2024

A Florida state policy set amid a measles outbreak in Broward County has vaccination proponents aghast, with many saying it leaves unvaccinated children especially vulnerable to the highly contagious disease. In a letter dated Tuesday about an outbreak at Manatee Bay Elementary School in Weston, located northwest of Miami and west of Fort Lauderdale, the state’s surgeon general, Joseph Ladapo, said that while it is normal policy to tell unvaccinated children to stay home during an outbrea

Vaccines 363

Vaccines 363

Pharmaceutical Commerce

FEBRUARY 2, 2024

A dive into this market reveals that the latest numbers yield promising results—a global value of a worldwide $1.6 trillion—but it will continue to be attributed to past, present, and future healthcare spending.

116

116

The Pharmacist

FEBRUARY 14, 2024

The General Pharmaceutical Council (GPhC) has announced the appointment of five new members to its governing council, including a community pharmacist. Adeyemi (Ade) Williams, superintendent pharmacist and director of M J Williams Pharmacy, and lead pharmacist at the Bedminster Pharmacy, Bristol, will begin his term on 1 April 2024. Joining him will be Professor Dianne […] The post GPhC announces five new council members appeared first on The Pharmacist.

114

114

pharmaphorum

FEBRUARY 19, 2024

Learn how biotechnology trials are transforming clinical data management systems, leveraging machine learning and advanced protocols to enhance efficiency and accuracy in data collection and analysis.

123

123

Pharmaceutical Technology

FEBRUARY 28, 2024

AGTC-501 is in Phase II development for retinitis in the SKYLINE trial (NCT03316560) and addresses unmet needs within the retinitis space

122

122

BioPharma Dive

FEBRUARY 20, 2024

The biotech set a price of roughly $515,000 per patient for its therapy Amtagvi, the first to be approved based on a decades-old technique of using tumor-infiltrating lymphocytes.

114

114

STAT

FEBRUARY 22, 2024

When a psychology professor in Michigan looked through his data on interpersonal conflict a decade ago, he discovered something unexpected. The study , which examined differences across cultures and age groups, seemed to show Americans got wiser as they got older. Richard Nisbett was used to research showing poorer mental skills among elderly adults, but his work found they were better at recognizing multiple perspectives, encouraging compromise, and acknowledging the limits of their own knowled

363

363

Pharma Times

FEBRUARY 5, 2024

The aggressive brain cancer is responsible for over 3,000 cases in the UK every year

149

149

Pharmacy Times

FEBRUARY 2, 2024

Supplementation during pregnancy also reduced communication warning behaviors in children who developed autism compared to the children of women who did not take supplements.

Communication 64

Communication 64

pharmaphorum

FEBRUARY 29, 2024

Explore how innovation in healthcare can be scaled across hospitals and nations, driving transformation through research & development, biotech collaborations, and fostering start-ups in the industry.

Hospitals 121

Hospitals 121

Pharmaceutical Technology

FEBRUARY 26, 2024

Bayer’s oral tyrosine kinase inhibitor is currently in a Phase I trial estimated to enrol 460 patients.

132

132

BioPharma Dive

FEBRUARY 22, 2024

The startup’s Series C round will support a clinical-stage drug the company thinks could address some of the weaknesses of other KRAS-targeting medicines.

120

120